Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Prostate Ca Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

3 recruiting trials for Prostate Ca. Eligibility criteria explained in plain English.

TrialFinderData lists 3 Prostate Ca clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Across the trials that carry a phase, Phase 1 is the largest group at 50% (1 studies); the largest phase groups are Phase 1: 1, Phase 2: 1.

Research is led by AdventHealth (1), University of Vermont (1), Ankara University (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Darolutamide (drug, 1 trial), followed by Relugolix, Radical Prostatectomy.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors

Track Prostate Ca trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGPhase 1NCT06631521

Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer

The goal of this clinical trial is to determine the safety and feasibility of a new combination of darolutamide and relugolix as neoadjuvant therapy preceding radical...

Sponsor: AdventHealthEnrolling: 301 location
RECRUITINGPhase 2NCT06972875

Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer

This study is for men with prostate cancer who are experiencing hot flashes due to treatments that lower testosterone. Hot flashes can affect your quality of life and make it...

Sponsor: University of VermontEnrolling: 321 location
RECRUITINGNCT06612034

Prostate Cancer Care Disparity Analysis Project (ProGAP)

This international cross-sectional study seeks to evaluate global disparities in prostate cancer management by conducting a thorough comparison of key elements across countries...

Sponsor: Ankara UniversityEnrolling: 4001 location

Frequently Asked Questions

There are currently 3 clinical trials for Prostate Ca, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Prostate Ca, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Prostate Ca, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.